- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adicet Bio Inc (ACET)
The Adicet Bio share price today is 8.605, view NASDAQ ACET stock exchange data. Track the latest Adicet Bio share price with real-time updates on ACET stock performance including market cap, day range, 52-week range and dividend yield. Access ACET charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
8.605
+0.095(+1.12%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.510
8.759
52 wk Range
6.010
17.438
ACET is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.5108.759
52 wk Range
6.01017.438
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACET Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
34.833
Upside
+304.80%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Form 13D/A Adicet Bio For: 10 April
- Investing.com
- Form 13G Adicet Bio For: 13 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 34.833
(+304.80% Upside)
Adicet Bio Inc SWOT Analysis
Gamma-Delta Pionee | Adicet Bio leads in engineered gamma-delta T cell therapies, with promising candidates for lupus nephritis and renal cell carcinoma in Phase 1 trials |
Financial Fortitude | Strong cash position of $150.4M supports ongoing clinical trials, though rapid cash burn rate poses future funding challenges |
Expanding Horizons | Explore Adicet's ambitious pipeline expansion into multiple autoimmune conditions, showcasing the versatility of its innovative platform |
Market Valuation | With analyst price targets ranging from $4 to $8 per share, Adicet's current trading price of $0.69 presents a potential asymmetric upside opportunity |
Earnings
Latest Release
05-03-2026
EPS / Forecast
-2.84 / -0.19
Revenue / Forecast
-- / 2.5M
Compare ACET to Peers and Sector
Metrics to compare | ACET | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACETPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.0x | −0.5x | |
PEG Ratio | −0.04 | −0.20 | 0.00 | |
Price/Book | 0.6x | 2.5x | 2.6x | |
Price / LTM Sales | - | 6.0x | 3.2x | |
Upside (Analyst Target) | 164.4% | 266.3% | 47.8% | |
Fair Value Upside | Unlock | 9.0% | 5.9% | Unlock |
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company’s lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Adicet Bio (ACET) Share Price Today?
The Adicet Bio share price today is 8.605.
What is the current Adicet Bio (ACET) share price and day range?
As of 06-05-2026, the Adicet Bio share price is 8.605, with a previous close of 8.510. The share price has ranged from 8.510 to 8.759 today, while the 52-week range spans from 6.010 to 17.438.
What Is the Adicet Bio Market Cap?
As of today, Adicet Bio market cap is 92.550M.
What Is the Adicet Bio (ACET) Share Price Target?
The average 12-month share price target for Adicet Bio is 34.833, with a high estimate of 100 and a low estimate of 18. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +304.80% Upside potential.
What Is Adicet Bio's Earnings Per Share (TTM)?
The Adicet Bio EPS (TTM) is -16.949.
When Is the Next Adicet Bio Earnings Date?
Adicet Bio will release its next earnings report on 05-03-2026.
From a Technical Analysis Perspective, Is ACET a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Adicet Bio Trade On?
Adicet Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Adicet Bio?
The stock symbol for Adicet Bio is "ACET."
How Many Times Has Adicet Bio Stock Split?
Adicet Bio has split 2 times.
How Many Employees Does Adicet Bio Have?
Adicet Bio has 102 employees.
What Is the ACET Premarket Price?
ACET's last pre-market stock price is 8.530. The pre-market share volume is 792.000, and the stock has changed by 0.020, or 0.240%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.